Abstract
Surveys on the relationships between medical academia and the pharmaceutical industry have raised concerns over potential conflicts of interest. To address the issues, more medical schools are establishing policies and taking steps to limit the pharmaceutical industry's presence and influence on campus, though with different approaches. Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
